
        

        <feed xmlns="http://www.w3.org/2005/Atom"><title>Caraco Pharmaceutical Laboratories Ltd.</title><subtitle/><mm:pagination xmlns:mm="http://namespaces.mochila.com/media-marketplace" skip="0" count="20" numHits="9" time="1"/><author><name>Bay Ledger News Zone</name><email>bill@blnz.com</email></author><link rel="self" type="application/atom+xml" href="http://www.blnz.com/cos/caraco_pharmaceutical_laboratories_ltd..atom"/><updated/><id>tag:www.blnz.com,2009:cos/caraco_pharmaceutical_laboratories_ltd.</id><entry><title>US Supreme Court ruling supports generic drug makers</title><id>tag:www.blnz.com,2009:2012/04/18/Supreme_Court_ruling_supports_generic_3fd6</id><link href="http://www.blnz.com/news/2012/04/18/Supreme_Court_ruling_supports_generic_3fd6.html"/><summary>The US Supreme Court ruled that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.</summary><updated>2012-04-18T03:48:27Z</updated><source><author><name>AFP Global Edition</name></author></source><author><name>By Staff Reporter</name></author></entry><entry><title>Government asks top court to rule for generic drugmaker</title><id>tag:www.blnz.com,2009:2011/12/06/Government_asks_court_rule_generic_efd9</id><link href="http://www.blnz.com/news/2011/12/06/Government_asks_court_rule_generic_efd9.html"/><summary>WASHINGTON (Reuters) - The government urged the Supreme Court to rule in favor of a generic drugmaker in a case over how companies can fight brand-name rivals to get cheaper drugs to market.</summary><updated>2011-12-06T19:17:37Z</updated><source><author><name>Reuters US Online Report Health News</name></author></source><author><name>Anna Yukhananov</name></author></entry><entry><title>Government asks top court to rule for generic drugmaker</title><id>tag:www.blnz.com,2009:2011/12/05/Government_asks_court_rule_generic_3850</id><link href="http://www.blnz.com/news/2011/12/05/Government_asks_court_rule_generic_3850.html"/><summary>WASHINGTON (Reuters) - The government urged the Supreme Court to rule in favor of a generic drugmaker in a case over how companies can fight brand-name rivals to get cheaper drugs to market.</summary><updated>2011-12-05T23:25:37Z</updated><source><author><name>Reuters US Online Report Health News</name></author></source><author><name>Anna Yukhananov</name></author></entry><entry><title>Caraco gets FDA approval for generic Eloxatin</title><id>tag:www.blnz.com,2009:2010/03/11/Caraco_gets_approval_generic_Eloxatin_7232</id><link href="http://www.blnz.com/news/2010/03/11/Caraco_gets_approval_generic_Eloxatin_7232.html"/><summary>Caraco Pharmaceutical gets FDA approval for generic version of cancer drug Eloxatin. Caraco Pharmaceutical Laboratories Ltd. said Thursday it launched a generic version of Sanofi-Aventis' cancer treatment Eloxatin.</summary><updated>2010-03-11T19:54:11Z</updated><source><author><name>AP News</name></author></source><author><name>Staff</name></author></entry><entry><title>Mylan battles quality control concern; stock drops</title><id>tag:www.blnz.com,2009:2009/07/27/Mylan_battles_quality_control_concern_4526</id><link href="http://www.blnz.com/news/2009/07/27/Mylan_battles_quality_control_concern_4526.html"/><summary>BOSTON (Reuters) - U.S. regulators have begun investigating possible manufacturing violations by Mylan Inc &lt;MYL.O&gt;, the world's third-biggest generic drugmaker.</summary><updated>2009-07-27T20:06:26Z</updated><source><author><name>Reuters US Online Report Business News</name></author></source><author><name>Toni Clarke</name></author></entry><entry><title>Health Care Industry Getting Reform Fever</title><id>tag:www.blnz.com,2009:2009/07/10/Health_Care_Industry_Getting_Reform_ever</id><link href="http://www.blnz.com/news/2009/07/10/Health_Care_Industry_Getting_Reform_ever.html"/><summary>It's beginning to look as if key sectors of the health industry have decided that Washington's reforms will be good for business. Call it enlightened self-interest.</summary><updated>2009-07-10T22:05:00Z</updated><source><author><name>Investor's Business Daily</name></author></source><author><name>
            By PETER BENESH, INVESTOR'S BUSINESS DAILY
        </name></author></entry><entry><title>Feds Seize Alleged Seizure-Inducing Drugs</title><id>tag:www.blnz.com,2009:2009/06/27/Feds_Seize_Alleged_Seizure-Inducing_Drugs_0508</id><link href="http://www.blnz.com/news/2009/06/27/Feds_Seize_Alleged_Seizure-Inducing_Drugs_0508.html"/><summary>FDA acts to prevent repeated drug quality problems. U.S. Marshals, acting at the request of the Food and Drug Administration (FDA), have seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd., at the company's Michigan facilities in Detroit, Farmington Hills, and Wixom. The seizure also includes ingredients held at these same facilities.</summary><updated>2009-06-26T00:00:00Z</updated><source><author><name>consumeraffairs.com</name></author></source><author><name>ConsumerAffairs.com</name></author></entry><entry><title>U.S. seizes Caraco drugs over manufacturing problems</title><id>tag:www.blnz.com,2009:2009/06/25/US_seizes_Caraco_drugs_over_9079</id><link href="http://www.blnz.com/news/2009/06/25/US_seizes_Caraco_drugs_over_9079.html"/><summary>WASHINGTON (Reuters) - U.S. authorities seized generic medicines made by Caraco Pharmaceutical Laboratories Ltd at plants in Michigan following repeated violations of manufacturing standards, regulators said on Thursday.</summary><updated>2009-06-25T20:00:15Z</updated><source><author><name>Reuters US Online Report Domestic News</name></author></source><author><name>REUTERS</name></author></entry><entry><title>Recalls: Digoxin heart drug, clothing irons</title><id>tag:www.blnz.com,2009:2009/03/31/Product_Recalls_clothing_irons_9218</id><link href="http://www.blnz.com/news/2009/03/31/Product_Recalls_clothing_irons_9218.html"/><summary>Product Recalls: Digoxin heart medication tablets, clothing irons. The following recalls have been announced:</summary><updated>2009-04-01T01:00:25Z</updated><source><author><name>AP News</name></author></source><author><name>The Associated Press</name></author></entry></feed>
      